Inhibrx Biosciences Inc.
USD93.50
-2.00 (-2.09%)
CEO
Mark Lappe
IPO Date
2024-05-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$95.41
Prev. Close
$95.50
Day Low
$93.13
Day High
$95.66
52W Low
$13.97
52W High
$155.29
Market Cap
$1.37B
Volume
0.15M
| 0.1 |
| 31 Dec 2023 | FY | 33.8% | -13408.9% | -554.8% | -78.4% | 4.83 | 5.25 | -7.4 |
| 31 Dec 2022 | FY | -4926.7% | -6625.3% | -250.1% | -49.9% | 3.57 | 10.17 | -6.8 |
| 31 Dec 2021 | FY | 62.3% | -1147.6% | -156.1% | -54.3% | 1.38 | 6.20 | -20.3 |
| 31 Dec 2020 | FY | -473.8% | -590.5% | -100.2% | -52.6% | 0.50 | 4.21 | -11.0 |
| 31 Dec 2019 | FY | -426.9% | -565.3% | 54.9% | -194.0% | -0.45 | 0.76 | -14.7 |
| 31 Dec 2018 | FY | -346.1% | -415.5% | 54.1% | -312.1% | -0.16 | 0.35 | -17.9 |
| 31 Dec 2017 | FY | -220.9% | -244.6% | 67.6% | -112.7% | -0.51 | 1.73 | -30.5 |
| 31 Dec 2016 | FY | -154.9% | -124.0% | 89.4% | -38.9% | -2.05 | 3.87 | -91.2 |
| -9.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -95.7% | -19.9% | 0.19 | 4.49 | -3.7 |
| 30 Jun 2025 | Q2 | 49.1% | -2204.2% | -41.8% | -13.5% | 1.56 | 4.98 | -1.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -45.9% | -17.8% | 1.13 | 5.12 | -1.2 |
| 31 Dec 2024 | Q4 | -589.0% | -47865.0% | -35.8% | -26.5% | 0.06 | 3.94 | -1.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -24.6% | -19.7% | 0.01 | 4.70 | -1.4 |
| 30 Jun 2024 | Q2 | 100.0% | 1858011.0% | 847.0% | 719.0% | 0.01 | 6.20 | 0.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -680.4% | -27.3% | 18.23 | 3.82 | -6.0 |
| 31 Dec 2023 | Q4 | 81.8% | -5728.5% | -215.2% | -30.4% | 4.83 | 5.25 | -5.5 |